SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter

Nature Neuroscience

Volumn 2, Issue 5, 1999, Pages 427-433

  Trotti, Davide ^a   Rolfs, Andreas ^a   Danbolt, Niels C ^b   Brown Jr , Robert H ^c   Hediger, Matthias A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE TRANSPORTER; HYDROGEN PEROXIDE; PEROXYNITRITE; SUPEROXIDE DISMUTASE;

AEROBIC METABOLISM; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CHELATION; GENE MUTATION; NERVE CELL DEGENERATION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEM X-AG; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; HUMANS; MUTATION; NEUROGLIA; OOCYTES; SUPEROXIDE DISMUTASE; XENOPUS;

EID: 0033366461     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/8091     Document Type: Article

References (48)

1. Rosen, D. R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (1993).
2. Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772-1775 (1994).
3. Bruijn, L. I. et al. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 94, 7606-7611 (1997).
4. Bogdanov, M. B., Ramos, L. E., Xu, Z. & Beal, M. F. Elevated hydroxyl radical generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 71, 1321-1324 (1998).
5. Ferrante, R. J. et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064-2074 (1997).
6. Borchelt, D. R. et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 91, 8292-8296 (1994).
7. Borchelt, D. R. et al. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. Biol. Chem. 270, 3234-3238 (1995).
8. Deng, H-X. et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261, 1047-1051 (1993).
9. Yim, H-S., Kang, J-H., Chock, P. B., Stadtman, E. R. & Yim, M. B. A familial amyotrophic lateral sclerosis-associated A4V Cu, Zn superoxide dismutase mutant has a lower Km for hydrogen peroxide. Correlation between clinical severity and the Km value. J. Biol. Chem. 272, 8861-8863 (1997).
10. Wiedau-Pazos, M. et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518 (1996).
11. Yim, M. B. et al. A gain of function of an amyotrophic lateral sclerosis-associated Cu, Zn superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA 93, 5709-5714 (1996).
12. Rothstein, J. D. et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686 (1996).
13. Haugeto, O. et al. Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 271, 27715-27722 (1996).
14. Lehre, K. P. & Danbolt, N. C. The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J. Neurosci. 18, 8751-8757 (1998).
15. Rothstein, J. D., Martin, L. J. & Kuncl, R. W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468 (1992).
16. Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J. & Kuncl, R. W. Selective loss of glial glutamate transporter GLT1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84 (1995).
17. Bristol, L. A. & Rothstein, J. D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 39, 676-679 (1996).
18. Aoki, M. et al. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann. Neurol. 43, 645-653 (1998).
19. Lin, C-L. G. et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589-602 (1998).
20. Canton, T., Pratt, J., Stutzmann, J-M., Imperato, A. & Boireau, A. Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport 9, 775-778 (1998).
21. Bruijin, L. I. et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338 (1997).
22. Pedersen, W. A. et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 44, 819-824 (1998).
23. Trotti, D. et al. Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271, 5976-5979 (1996).
24. Trotti, D., Nussberger, S., Volterra, A. & Hediger, M. A. Differential modulation of the uptake currents by redox interconversion of cysteine residues in the human neuronal glutamate transporter EAAC1. Eur. J. Neurosci. 9, 2207-2212 (1997).
25. Trotti, D., Danbolt, N. C. & Volterra, A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 19, 328-334 (1998).
26. Taylor, P. M., Kaur, S., Mackenzie, B. & Peter, G. J. Amino-acid-dependent modulation of amino acid transporter in Xenopus laevis oocytes. J. Exp. Biol. 199, 923-931 (1996).
27. Robberecht, W. et al. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 62, 384-387 (1994).
28. Tu, P-H., Gurney, M. E., Julien, J-P., Lee, V. M. & Trojanowski, J. Q. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab. Invest. 76, 441-456 (1997).
29. Siddique, T. & Deng, H. X. Genetics of amyotrophic lateral sclerosis. Hum. Mol. Gen. 5, 1465-1470 (1996).
30. Gillis, K. D. in Single Channel Recording 2nd edn. (eds. Sakmann, B. & Neher, E.) 155-198 (Plenum, New York, 1995).
31. Davies, K. J., Delsignore, M. E. & Lin, S. W. Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J. Biol. Chem. 262, 9902-9907 (1987).
32. Zerangue, N. & Kavanaugh, M. P. Flux coupling in a neuronal glutamate transporter. Nature 383, 634-637 (1996).
33. Davies, K. J. Protein damage and degeneration by oxygen radicals. I. General aspects. J. Biol. Chem. 262, 9895-9901 (1987).
34. Grunewald, M., Bendahan, A. & Kanner, B. I. Biotinylation of single cysteine mutants of the glutamate transporter GLT1 from rat brain reveals its unusual topology. Neuron 21, 623-632 (1998).
35. Day, B. J., Fridovich, I. & Crapo, J. D. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch. Biochem. Biophys. 347, 256-262 (1997).
36. Batinic-Haberle, I., Liochev, S. I., Spasojevic, I. & Fridovich, I. A potent superoxide dismutase mimic: Manganese β-octabromo-meso-etrakis-(N-methylpyridinium-4-yl) porphyrin. Arch. Biochem. Biophys. 343, 225-233 (1997).
37. Mu, X., He, J., Anderson, D. W., Trojanowski, J. Q. & Springer, J. E. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40, 379-386 (1996).
38. Eisen, A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve 18, 741-752 (1995).
39. Brown, R. H. Jr. Free radicals, programmed cell death and muscular dystrophy. Curr. Opin. Neurol. 8, 373-378 (1995).
40. Brown, R. H. Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80, 687-692 (1995).
41. van Iwaarden, P. R., Driessen, A. J. & Koning, W. N. What we can learn from the effects of thiol reagents on transport proteins. Biochem. Biophys. Acta 1113, 161-170 (1992).
42. Davies, K. J. A. & Delsignore, M. E. Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. J. Biol. Chem. 262, 9908-9913 (1987).
43. Davies, K. J. A., Lin, S. W. & Pacifici, R. E. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. J. Biol. Chem. 262, 9914-9920 (1987).
44. Tanaka, K. et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT1. Science 276, 1699-1702 (1997).
45. Bensimon, G., Lacomblez, L. & Meininger, V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/riluzole study group. N. Engl. J. Med. 330, 585-591 (1994).
46. Lacomblez, L., Bensimon, G., Leigh, P. N., Guillet, P. & Meininger, V. Doseranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis/riluzole study group II. Lancet 347, 1425-1431 (1996).
47. Gurney, M. E., Fleck, T. J., Himes, C. S. & Hall, E. D. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Neurology 50, 62-66 (1998).
48. Arriza, J. L. et al. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14, 5559-5569 (1994).